´ëÇѾÏÇÐȸ 2023 AACR-KCA Joint Conference on Precision Medicine in Cancer (2ÀÏÂ÷) : 2023-11-16
±³À°ÀÏÀÚ : 2023-11-16
±³À°Àå¼Ò : ¼¿ï·Ôµ¥È£ÅÚ 2, 3Ãþ
±³À°ÁÖÁ¦ : 2023 AACR-KCA Joint Conference on Precision Medicine in Cancer (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬
¿¬¶ôó : 02-792-1486
À̸ÞÀÏ : cancer2@kams.or.kr
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú, ¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ
Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 5ºÐ
¼¼ºÎ¼ö°·á : 400,000¿ø
ºñ°í "1. »çÀüµî·Ï: 1) ȸ¿ø 10¸¸¿ø, 2)ȸ¿ø(¾÷ü), ºñȸ¿ø 20¸¸¿ø, 3) ºñȸ¿ø(¾÷ü) 30¸¸¿ø, 4) Àü°øÀÇ/´ëÇпø»ý: 7¸¸¿ø
2. ÀϹݵî·Ï: 1) ȸ¿ø 20¸¸¿ø, 2)ȸ¿ø(¾÷ü), ºñȸ¿ø 30¸¸¿ø, 3) ºñȸ¿ø(¾÷ü) 40¸¸¿ø, 4) Àü°øÀÇ/´ëÇпø»ý: 10¸¸¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 08:30~08:50 Circulating tumor DNA analysis for detection and monitoring of lung cancer Maximilian Diehn(Stanford University, Stanford, CA)
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 08:55~09:15 Cancer detection and monitoring using whole genome methylation sequencing ¹æµÎÈñ(¿¬¼¼´ë)
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 09:20~09:40 Hereditary cancer surveillance uing cell-free DNA sequencing Trevor J. Pugh(University of Toronto, Toronto, ON)
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 09:45~10:10 Multi cancer early detection by Exosome-SERS-AI ÃÖ¿¬È£(°í·Á´ë)
ÈÞ½Ä 11¿ù 16ÀÏ 10:10~10:30 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 10:30~11:10 Early detection of cancer using cell-free DNA fragmentomes Victor E. Velculescu(Johns Hopkins University School of Medicine, Baltimore, MD)
±³À°½Ã°£ 11¿ù 16ÀÏ »çÆÄÀ̾·ë 11:20~12:00 Present and future of osimertinib as the backbone therapy of EGFRm NSCLC È«¹ÎÈñ(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 11¿ù 16ÀÏ 12:00~12:30 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 12:30~12:55 Imaging and quality assurance for emerging radiation technologies: Experiences of IROC for the NCI NCTN and beyond Michael V. Knopp(University of Cincinnati, Cincinnati, OH)
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 12:55~13:20 Reinventing radiobiology in the light of FLASH radiotherapy Àå¿øÀÏ(¿øÀڷº´¿ø)
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 13:20~13:45 Preclinical studies with proton FLASH radiotherapy in mouse models and canines Constantinos Koumenis(University of Pennsylvania, Philadelphia, PA)
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 13:45~14:10 Repair of heavy ion radiation-induced complex DNA double-strand breaks Kei-ichi Takata(±âÃÊ°úÇבּ¸¿ø(IBS))
ÈÞ½Ä 11¿ù 16ÀÏ 14:10~14:30 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 14:30~14:55 Metabolic vulnerabilities as therapeutic targets in ovarian cancer Adekunle Odunsi(University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL)
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 14:55~15:20 Tumor-associated monocytes and neutrophils: Targets for immunotherapy? Á¤±âÈÆ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 15:20~15:45 Targeting cancer-associated fibroblasts to enhance immunotherapy: Characterising heterogeneity and exploiting plasticity Gareth Thomas(University of Southampton, Southampton)
±³À°½Ã°£ 11¿ù 16ÀÏ Å©¸®½ºÅ»º¼·ë 15:45~16:10 How is tumor immunity regulated in fibrotic gastric cancers? ÇãÈÆ(¾ÆÁÖÀÇ´ë)